Svenska                Glossary                Search    
 
 
AboutTechnologyProjectInvestorMedia Releases 2010Contact
 
 
 
frontpage_pic3.png

   
Latest News Upcoming Events
   
   
December 6, 2011
NeuroNova concludes a first-in-human study with a novel treatment for patients with Parkinson´s disease
March 10, 2011
NeuroNova founder Professor Jonas Frisén awarded the AkzoNobel Science Award 2011
 


   
© NeuroNova AB, Sweden, Tel: +46 (0)8 786 0900, Email: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

Sitemap   Site policy
Site last updated: Tuesday 6 December 2011  
 
 
Project Pipeline

Project

    Indication  

Pre-clin.

   IND  

 Phase I/II

 Phase II

 Phase III 

sNN0029ALS      
sNN0031Parkinson's disease     
More about our ProjectsImage

 Business Development

NeuroNova’s business strategy centers on developing novel therapeutic products based on neurogenesis in areas of high unmet medical need in neurodegenerative diseases.
More about business development.Image